ArticleJournal of clinical medicine2019

Higher Serum Testosterone Levels Associated with Favorable Prognosis in Enzalutamide- and Abiraterone-Treated Castration-Resistant Prostate Cancer.

Shinichi Sakamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.